R-Zero
About the author
When it comes to infection prevention, we need a new normal. Norovirus impacts 19-21 million Americans and costs US$2 billion annually. Influenza impacts 30 to 40 million Americans and costs US$10.4 billion annually.
R-Zero developed a suite of solutions to greatly reduce the damage each of these viruses causes to our personal and economic health. We are establishing a new standard for public health.
R-Zero is a biosafety company dedicated to making safer spaces and common places. We design effective technologies and protocols to reduce deadly pathogens—today and forever.
Number Of Publications
5 articles
Case Study: LeRoy Community Unity School District 2
For students across the country, pre-pandemic educational gaps in access, opportunities, achievement, and outcomes felt irreparably widened by the emergence of COVID-19. […]
R-Zero and Science-Backed Efficacy
COVID-19 has caused regular people to pay more attention to science-backed efficacy. As the pandemic progressed, human-to-human interaction in confined, indoor spaces […]
Keeping Schools Open: A Moderated Discussion about Minimizing Learning Loss Amid Omicron
The challenging issue of keeping schools open has forced the public education system to confront the social and educational consequences associated with […]
How ESSER Funding Can Help Future-Proof Your School
Since the COVID-19 pandemic began, the U.S. government has provided Elementary & Secondary School Emergency Relief (ESSER) funds to support schools in […]
Beyond the Pandemic: The Critical Role of Facilities Managers, and the New Technologies Empowering Them
As humans, we spend 90% of our time indoors. The COVID-19 pandemic has increased the critical need for the common indoor spaces […]